Literature DB >> 29557395

Prostate cancer: A novel mechanism of neuroendocrine transdifferentiation.

Louise Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29557395     DOI： 10.1038/nrurol.2018.40

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.

Authors:  Xinpei Ci; Jun Hao; Xin Dong; Stephen Y Choi; Hui Xue; Rebecca Wu; Sifeng Qu; Peter W Gout; Fang Zhang; Anne M Haegert; Ladan Fazli; Francesco Crea; Christopher J Ong; Amina Zoubeidi; Housheng H He; Martin E Gleave; Colin C Collins; Dong Lin; Yuzhuo Wang
Journal:  Cancer Res       Date:  2018-02-27       Impact factor: 12.701
  1 in total
  2 in total

Review 1.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04

2.  The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

Authors:  Varune Rohan Ramnarine; Mohammed Alshalalfa; Fan Mo; Noushin Nabavi; Nicholas Erho; Mandeep Takhar; Robert Shukin; Sonal Brahmbhatt; Alexander Gawronski; Maxim Kobelev; Mannan Nouri; Dong Lin; Harrison Tsai; Tamara L Lotan; R Jefferey Karnes; Mark A Rubin; Amina Zoubeidi; Martin E Gleave; Cenk Sahinalp; Alexander W Wyatt; Stanislav V Volik; Himisha Beltran; Elai Davicioni; Yuzhuo Wang; Colin C Collins
Journal:  Gigascience       Date:  2018-06-01       Impact factor: 6.524
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.